Institutional Manager · CIK 0001993440
First Turn Management, LLC
DEL MAR, CA · File #028-23631
Latest AUM
$875.2M
Positions
33
Top-10 Concentration
47.3%
Filings
8
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | TERNS PHARMACEUTICALS INC | TERN | +872,049 | +$35.2M | $0 |
| EXITED | MERUS N V | N5749R100 | -372,022 | -$35.0M | $0 |
| NEW | COGENT BIOSCIENCES INC | COGT | +824,283 | +$29.3M | $0 |
| NEW | GUARDANT HEALTH INC | GH | +271,685 | +$27.7M | $0 |
| EXITED | ARCELLX INC | 03940C100 | -313,733 | -$25.8M | $0 |
| EXITED | NEUROCRINE BIOSCIENCES INC | 64125C109 | -181,897 | -$25.5M | $0 |
| NEW | IDEAYA BIOSCIENCES INC | IDYA | +723,653 | +$25.0M | $0 |
| NEW | VIRIDIAN THERAPEUTICS INC | VRDN | +690,528 | +$21.5M | $0 |
| NEW | FULCRUM THERAPEUTICS INC | FULC | +1,892,683 | +$21.4M | $0 |
| NEW | SCHOLAR ROCK HLDG CORP | SRRK | +459,727 | +$20.3M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202533 pos · $875.2M
- 13F HOLDINGS REPORTQ/E Sep 202529 pos · $666.0M
- 13F HOLDINGS REPORTQ/E Jun 202535 pos · $536.0M
- 13F HOLDINGS REPORTQ/E Mar 202535 pos · $496.1M
- 13F HOLDINGS REPORTQ/E Dec 202436 pos · $558.3M
- 13F HOLDINGS REPORTQ/E Sep 202438 pos · $631.6M
- 13F HOLDINGS REPORTQ/E Jun 202436 pos · $614.7M
- 13F HOLDINGS REPORTQ/E Mar 202434 pos · $668.5M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | ABIVAX SA | AAVXF | 381,233 | $51.4M | 5.87% |
| 2 | REVOLUTION MEDICINES INC | RVMDW | 638,385 | $50.8M | 5.81% |
| 3 | INSMED INC | INSM | 264,293 | $46.0M | 5.26% |
| 4 | BRIDGEBIO PHARMA INC | BBIO | 595,473 | $45.5M | 5.20% |
| 5 | MIRUM PHARMACEUTICALS INC | MIRM | 481,564 | $38.0M | 4.35% |
| 6 | AXSOME THERAPEUTICS INC | AXSM | 206,921 | $37.8M | 4.32% |
| 7 | NUVALENT INC | NUVL | 368,697 | $37.1M | 4.24% |
| 8 | XENON PHARMACEUTICALS INC | XENE | 799,743 | $35.8M | 4.10% |
| 9 | APOGEE THERAPEUTICS INC | APGE | 474,839 | $35.8M | 4.10% |
| 10 | TERNS PHARMACEUTICALS INC | TERN | 872,049 | $35.2M | 4.03% |
| 11 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 893,473 | $31.3M | 3.58% |
| 12 | UNITED THERAPEUTICS CORP DEL | UTHR | 63,580 | $31.0M | 3.54% |
| 13 | VERA THERAPEUTICS INC | VERA | 601,774 | $30.5M | 3.48% |
| 14 | COGENT BIOSCIENCES INC | COGT | 824,283 | $29.3M | 3.35% |
| 15 | ASCENDIS PHARMA A/S | ASND | 131,808 | $28.1M | 3.21% |
| 16 | GUARDANT HEALTH INC | GH | 271,685 | $27.7M | 3.17% |
| 17 | ROIVANT SCIENCES LTD | ROIV | 1,186,817 | $25.8M | 2.94% |
| 18 | IDEAYA BIOSCIENCES INC | IDYA | 723,653 | $25.0M | 2.86% |
| 19 | VIRIDIAN THERAPEUTICS INC | VRDN | 690,528 | $21.5M | 2.46% |
| 20 | FULCRUM THERAPEUTICS INC | FULC | 1,892,683 | $21.4M | 2.45% |